Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 56,012 shares at $86.12 ($4.6M) on 2016-03-02, disclosed to the SEC on 2016-03-02.
Open-market sale of $4.6M BMRN by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.87 | 46,766 | $3.8M | 82.8% |
| 2 | $86.12 | 4,623 | $398K | 8.6% |
| 3 | $86.12 | 4,623 | $398K | 8.6% |
| Total | $82.57 avg | 56,012 | $4.6M | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |